person · Reporting owner

DUSKIN JONATHAN

Disclosed activity across 3 companies

Tapewire entity: 84715
SEC CIK: 0001350166

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CHRISTOPHER & BANKS CORPCBKC · Entity 143842	Director · 10% owner	June 17, 2020	June 18, 2020
Citi Trends IncCTRN · Entity 5399	Director	December 26, 2024	December 28, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CHRISTOPHER & BANKS CORP

Report date June 17, 2020 · Filed June 18, 2020

Jointly reported with Macellum Retail Opportunity Fund, LP, Macellum Capital Management, LLC, Macellum Advisors GP, LLC, Macellum Management, LP, MCM Managers, LLC, MCM Management, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	230,303	Reported balance After 2020-06-17 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2020-06-17 · Grant · Acquired 50,000 · Balance 230,303 F1: On June 17, 2020, Jonathan Duskin was granted 50,000 shares of common stock of Christopher & Banks Corporation (the "Issuer") pursuant to the terms of a Restricted Stock Agreement (the "Agreement") between the Issuer and Mr. Duskin. Subject to forfeiture provisions set forth in the Agreement, the shares awarded vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders. F2: This number includes restricted stock awards.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	4,790,597	Reported balance Holding disclosure · report date 2020-06-17 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 4,790,597 F3: Represents shares of common stock of the Issuer directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	68,313	Reported balance Holding disclosure · report date 2020-06-17 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 68,313 F5: Represents shares of common stock of the Issuer directly held by Macellum Capital Management, LLC ("Macellum Capital Management"). MCM Managers, LLC ("MCM Managers") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Macellum Capital Management as the managing member of Macellum Capital Management. MCM Management, LLC ("MCM Management") may be deemed to have voting and investment power over such shares as the managing member of MCM Managers. Mr. Duskin may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Macellum Capital Management as the managing member of MCM Management. MCM Managers, MCM Management and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Macellum Capital Management due to MCM Managers' right to receive a performance-based allocation. F6: (Continued from Footnote 6) Each of MCM Managers, MCM Management and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Macellum Capital Management except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of MCM Managers, MCM Management or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: On June 17, 2020, Jonathan Duskin was granted 50,000 shares of common stock of Christopher & Banks Corporation (the "Issuer") pursuant to the terms of a Restricted Stock Agreement (the "Agreement") between the Issuer and Mr. Duskin. Subject to forfeiture provisions set forth in the Agreement, the shares awarded vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders.

F2: This number includes restricted stock awards.

F3: Represents shares of common stock of the Issuer directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP.

F4: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

F5: Represents shares of common stock of the Issuer directly held by Macellum Capital Management, LLC ("Macellum Capital Management"). MCM Managers, LLC ("MCM Managers") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Macellum Capital Management as the managing member of Macellum Capital Management. MCM Management, LLC ("MCM Management") may be deemed to have voting and investment power over such shares as the managing member of MCM Managers. Mr. Duskin may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Macellum Capital Management as the managing member of MCM Management. MCM Managers, MCM Management and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Macellum Capital Management due to MCM Managers' right to receive a performance-based allocation.

F6: (Continued from Footnote 6) Each of MCM Managers, MCM Management and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Macellum Capital Management except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of MCM Managers, MCM Management or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

Citi Trends Inc

Report date December 26, 2024 · Filed December 28, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Macellum Home Fund, LP	33,396	Reported balance After 2024-12-26 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2024-12-26 · Sale · Disposed 12,000 · Balance 33,396 F1: 1. Reflects the weighted average sale price of multiple open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by broker-dealer. The range of prices for the sale transactions was $25.96 to $26.75. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: 1. Reflects the weighted average sale price of multiple open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by broker-dealer. The range of prices for the sale transactions was $25.96 to $26.75. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

BIG LOTS INC

Report date April 13, 2020 · Filed April 15, 2020

Jointly reported with Macellum Opportunity Fund LP, Macellum Management, LP, Macellum Advisors GP, LLC

Section 16 reporting ended · disclosed 2020-04-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock $0.01 par valueSEC Table I · non-derivative	IndirectSee Footnote	926,612	Reported balance After 2020-04-14 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2020-04-14 · Other · Acquired 73,500 · Balance 926,612 F1: This Form 4 is filed jointly by Macellum Opportunity Fund LP ("Macellum Opportunity"), Macellum Management, LP ("Macellum Management"), Macellum Advisors GP, LLC ("Macellum GP") and Jonathan Duskin (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously owned more than 10% of the Issuer's outstanding shares of Common Stock, par value $0.01 (the "Common Stock"). As of April 14, 2020, the Reporting Persons ceased to own in the aggregate more than 10% of the Issuer's outstanding Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F2: Securities owned directly by Macellum Opportunity. As the investment manager of Macellum Opportunity, Macellum Management may be deemed to beneficially own the securities owned directly by Macellum Opportunity. As the general partner of Macellum Opportunity, Macellum GP may be deemed to beneficially own securities owned directly by Macellum Opportunity. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities owned directly by Macellum Opportunity.
Call Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.50 · Expires 2020-04-17	IndirectSee Footnote	157,500	Reported balance After 2020-04-13 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-04-13 · Sale · Disposed 675 · Balance 157,500 F2: Securities owned directly by Macellum Opportunity. As the investment manager of Macellum Opportunity, Macellum Management may be deemed to beneficially own the securities owned directly by Macellum Opportunity. As the general partner of Macellum Opportunity, Macellum GP may be deemed to beneficially own securities owned directly by Macellum Opportunity. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities owned directly by Macellum Opportunity.
Call Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.50 · Expires 2020-04-17	IndirectSee Footnote	73,500	Reported balance After 2020-04-14 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-04-14 · Sale · Disposed 840 · Balance 73,500 F2: Securities owned directly by Macellum Opportunity. As the investment manager of Macellum Opportunity, Macellum Management may be deemed to beneficially own the securities owned directly by Macellum Opportunity. As the general partner of Macellum Opportunity, Macellum GP may be deemed to beneficially own securities owned directly by Macellum Opportunity. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities owned directly by Macellum Opportunity.
Call Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.50 · Expires 2020-04-17	IndirectSee Footnote	0	Reported balance After 2020-04-14 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-04-14 · Other · Disposed 735 · Balance 0 F2: Securities owned directly by Macellum Opportunity. As the investment manager of Macellum Opportunity, Macellum Management may be deemed to beneficially own the securities owned directly by Macellum Opportunity. As the general partner of Macellum Opportunity, Macellum GP may be deemed to beneficially own securities owned directly by Macellum Opportunity. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities owned directly by Macellum Opportunity.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by Macellum Opportunity Fund LP ("Macellum Opportunity"), Macellum Management, LP ("Macellum Management"), Macellum Advisors GP, LLC ("Macellum GP") and Jonathan Duskin (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously owned more than 10% of the Issuer's outstanding shares of Common Stock, par value $0.01 (the "Common Stock"). As of April 14, 2020, the Reporting Persons ceased to own in the aggregate more than 10% of the Issuer's outstanding Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2: Securities owned directly by Macellum Opportunity. As the investment manager of Macellum Opportunity, Macellum Management may be deemed to beneficially own the securities owned directly by Macellum Opportunity. As the general partner of Macellum Opportunity, Macellum GP may be deemed to beneficially own securities owned directly by Macellum Opportunity. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities owned directly by Macellum Opportunity.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 13, 2018 Filed Jun 14, 2018 16:33 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	GrantCommon Stock	50,000	$0.00	$0.00	Disclosure SEC source: 0000883943-18-000086 · wf-form4_152900838997511.xml · nonDerivative · entry 1 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,303 F1 · kind: The reporting person was awarded 50,000 shares of Common Stock pursuant to a Restricted Stock Agreement. Subject to the forfeiture provisions set forth in the Agreement, the shares awarded vest in full on the earlier of (i) June 13, 2019 or (ii) the date of the Company's 2019 Annual Meeting of Stockholders. F2 · balance_after: This number includes restricted stock awards. Read SEC document
June 06, 2018 Filed Jun 8, 2018 21:00 UTC	Citi Trends Inc CTRN · Entity 5399	GrantCommon Stock, $0.01 par value	2,397	$0.00	$0.00	Disclosure SEC source: 0000921895-18-001894 · form411142001_06082018.xml · nonDerivative · entry 1 DUSKIN JONATHAN · CIK 0001350166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,009 F1 · shares: Represents shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer. The restricted stock will vest one year after the date of grant, which would be June 6, 2019, provided Mr. Duskin is a director of the Issuer at such time. Read SEC document
May 30, 2018 Filed May 31, 2018 21:30 UTC	Citi Trends Inc CTRN · Entity 5399	SaleCommon Stock, $0.01 par value	1,500	$30.50	$45,742.50	Disclosure SEC source: 0000921895-18-001855 · form411142003_05312018.xml · nonDerivative · entry 3 DUSKIN JONATHAN · CIK 0001350166 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Macellum SPV III, LP Disclosed balance after: 514,810 F4 · price: The price reported is a weighted average price. The reported shares were purchased in multiple transactions at prices ranging from $30.45 to $30.55. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4. F3 · ownership.nature: Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document
May 29, 2018 Filed May 31, 2018 21:30 UTC	Citi Trends Inc CTRN · Entity 5399	SaleCommon Stock, $0.01 par value	10,500	$29.86	$313,540.50	Disclosure SEC source: 0000921895-18-001855 · form411142003_05312018.xml · nonDerivative · entry 2 DUSKIN JONATHAN · CIK 0001350166 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Macellum SPV III, LP Disclosed balance after: 516,310 F2 · price: The price reported is a weighted average price. The reported shares were purchased in multiple transactions at prices ranging from $29.68 to $30.52. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2. F3 · ownership.nature: Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document
June 21, 2017 Filed Jul 5, 2017 22:29 UTC	Citi Trends Inc CTRN · Entity 5399	GrantCommon Stock, $0.01 par value	2,612	$0.00	$0.00	Disclosure SEC source: 0001193805-17-001255 · e616361_4-duskin.xml · nonDerivative · entry 1 DUSKIN JONATHAN · CIK 0001350166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,612 F1 · shares: Represents shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer. The restricted stock will vest one year after the date of grant provided Mr. Duskin is a director of the Issuer at such time. Read SEC document
June 16, 2017 Filed Jun 20, 2017 08:55 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	10,000	$1.31	$13,071.00	Disclosure SEC source: 0000883943-17-000104 · wf-form4_149796331745221.xml · nonDerivative · entry 2 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,432,457 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.32, inclusive. The reporting person will provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
June 14, 2017 Filed Jun 16, 2017 09:06 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	GrantCommon Stock	50,000	$0.00	$0.00	Disclosure SEC source: 0000883943-17-000102 · wf-form4_149761836669818.xml · nonDerivative · entry 1 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,303 F1 · kind: The reporting person was awarded 50,000 shares of Common Stock pursuant to a Restricted Stock Agreement. Subject to the forfeiture provisions set forth in the Agreement, the shares awarded vest in full on the earlier of (i) June 14, 2018 or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. F2 · balance_after: This number includes restricted stock awards. Read SEC document
June 14, 2017 Filed Jun 16, 2017 08:48 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	2,500	$1.36	$3,400.00	Disclosure SEC source: 0000883943-17-000092 · wf-form4_149761732000714.xml · nonDerivative · entry 2 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,422,457 F2 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F3 · ownership.nature: (Continued from Footnote 2) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
June 13, 2017 Filed Jun 14, 2017 11:55 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	20,000	$1.36	$27,292.00	Disclosure SEC source: 0000883943-17-000090 · wf-form4_149745573172898.xml · nonDerivative · entry 3 DUSKIN JONATHAN · CIK 0001350166 · Director Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,419,957 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.38, inclusive. The reporting person will provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
June 12, 2017 Filed Jun 14, 2017 11:55 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	10,000	$1.34	$13,371.00	Disclosure SEC source: 0000883943-17-000090 · wf-form4_149745573172898.xml · nonDerivative · entry 2 DUSKIN JONATHAN · CIK 0001350166 · Director Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,399,957 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.31 to $1.36, inclusive. The reporting person will provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
May 31, 2017 Filed Jun 1, 2017 16:10 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	20,000	$1.35	$27,046.00	Disclosure SEC source: 0000883943-17-000086 · wf-form4_149634782927806.xml · nonDerivative · entry 3 DUSKIN JONATHAN · CIK 0001350166 · Director Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,389,957 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.36, inclusive. The reporting person will provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
May 30, 2017 Filed Jun 1, 2017 16:10 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	80,000	$1.33	$106,128.00	Disclosure SEC source: 0000883943-17-000086 · wf-form4_149634782927806.xml · nonDerivative · entry 2 DUSKIN JONATHAN · CIK 0001350166 · Director Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,369,957 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.34, inclusive. The reporting person will provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
May 26, 2017 Filed May 31, 2017 16:44 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	100,000	$1.27	$126,950.00	Disclosure SEC source: 0000883943-17-000084 · wf-form4_149626345820119.xml · nonDerivative · entry 2 DUSKIN JONATHAN · CIK 0001350166 · Director Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,289,957 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.30, inclusive. The reporting person will provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
March 29, 2017 Filed Mar 29, 2017 17:23 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	74,294	$1.47	$109,241.90	Disclosure SEC source: 0000883943-17-000062 · wf-form4_149082259786648.xml · nonDerivative · entry 8 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner · related entity to 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,189,957 F10 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.49, inclusive. The reporting person will provide the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
March 28, 2017 Filed Mar 29, 2017 17:23 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	157,550	$1.46	$230,164.80	Disclosure SEC source: 0000883943-17-000062 · wf-form4_149082259786648.xml · nonDerivative · entry 7 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner · related entity to 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,115,663 F9 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.375 to $1.50, inclusive. The reporting person will provide the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
March 22, 2017 Filed Mar 29, 2017 17:23 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	5,000	$1.30	$6,485.00	Disclosure SEC source: 0000883943-17-000062 · wf-form4_149082259786648.xml · nonDerivative · entry 6 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner · related entity to 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,958,113 F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.325, inclusive. The reporting person will provide the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
March 21, 2017 Filed Mar 29, 2017 17:23 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	25,000	$1.32	$33,060.00	Disclosure SEC source: 0000883943-17-000062 · wf-form4_149082259786648.xml · nonDerivative · entry 5 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner · related entity to 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,953,113 F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.33, inclusive. The reporting person will provide the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
March 20, 2017 Filed Mar 29, 2017 17:23 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	30,000	$1.27	$38,115.00	Disclosure SEC source: 0000883943-17-000062 · wf-form4_149082259786648.xml · nonDerivative · entry 4 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner · related entity to 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,928,113 F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.285, inclusive. The reporting person will provide the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
March 17, 2017 Filed Mar 29, 2017 17:23 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	74,000	$1.28	$94,431.40	Disclosure SEC source: 0000883943-17-000062 · wf-form4_149082259786648.xml · nonDerivative · entry 3 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner · related entity to 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,898,113 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.25 to $1.29, inclusive. The reporting person will provide the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document
March 16, 2017 Filed Mar 29, 2017 17:23 UTC	CHRISTOPHER & BANKS CORP CBK · Entity 143842	PurchaseCommon Stock	10,000	$1.27	$12,679.00	Disclosure SEC source: 0000883943-17-000062 · wf-form4_149082259786648.xml · nonDerivative · entry 2 DUSKIN JONATHAN · CIK 0001350166 · Director · 10% owner · related entity to 10% owner Macellum Capital Management, LLC · CIK 0001468348 · Related legal entity Macellum Retail Opportunity Fund, LP · CIK 0001607223 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,824,113 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.28, inclusive. The reporting person will provide the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F3 · ownership.nature: Represents shares of common stock of Christopher & Banks Corporation (the "Issuer") directly held by Macellum Retail Opportunity Fund, LP ("Opportunity Fund"). Macellum Management, LP ("Macellum Management") may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund as the investment manager for Opportunity Fund. Macellum Advisors GP, LLC ("Macellum GP") may be deemed to have voting and investment power over such shares as the general partner of Opportunity Fund and of Macellum Management. Jonathan Duskin is the sole member of Macellum GP and may be deemed to have voting and investment power over the shares of common stock of the Issuer directly held by Opportunity Fund by virtue of his relationship with Macellum GP. F4 · ownership.nature: (Continued from Footnote 3) Macellum GP and Mr. Duskin may be deemed to have a pecuniary interest in the shares of common stock of the Issuer directly held by Opportunity Fund due to Macellum GP's right to receive a performance-based allocation. Each of Macellum Management, Macellum GP and Mr. Duskin disclaims beneficial ownership of the shares of common stock of the Issuer directly held by Opportunity Fund, except to the extent of their pecuniary interests therein. This report shall not be deemed an admission that any of Macellum Management, Macellum GP or Mr. Duskin is the beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.